Positive Preliminary Results From Phase 1 Trial of Dopaminergic Neuron Graft for Parkinson’s Disease | Docwire News
The primary safety endpoint of minimal SAEs was met as well as the secondary endpoint of increased fluorodopa in the putamen.
The primary safety endpoint of minimal SAEs was met as well as the secondary endpoint of increased fluorodopa in the putamen.
Treatment with the drug demonstrated lesion and pain control in moderate to severe disease.
Can you maintain good health into your 80s and beyond? Cardiologist Dr. Eric Topol says yes. He joins Dr. Sanjay Gupta explain why preventing the…
Peter Richardson and George Wan of Mallinckrodt discussed data on terlipressin for hepatorenal syndrome–acute kidney injury (HRS-AKI) presented at Digestive Disease Week 2025.
Drug combination targeting lax airways is nearing an FDA submission
In The 48 Laws of Power, Law 42 is “Strike the Shepherd and the Sheep Will Scatter.” Learn what Law 42 means and how to…
Reactive oxygen species levels decreased and patients with evident bone marrow failure showed hematological response.
Drug combination targeting lax airways is nearing an FDA submission
Keeping our minds healthy is just as important as keeping our body healthy. For many, one of the biggest fears as we age is the…
Investigation of a HUNT Study cohort found elevated plasma MBL levels to be associated with increased risk for future VTE.
Drug combination targeting lax airways is nearing an FDA submission